About Contact Us Careers

Chlorhexidine Gluconate (CHG) Wipes Market Size and Forecast, by Concentration (2%, 5%); Product Type; Application; Distribution Channel - Growth Trends, Key Players, Regional Analysis 2026-2035

  • Report ID: 1468
  • Published Date: Sep 08, 2025
  • Report Format: PDF, PPT

Chlorhexidine Gluconate Wipes Market Outlook:

Chlorhexidine Gluconate Wipes Market size was over USD 214.09 million in 2025 and is projected to reach USD 376.23 million by 2035, witnessing around 5.8% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of chlorhexidine gluconate wipes is assessed at USD 225.27 million.

Chlorhexidine Gluconate (CHG) Wipes Market Size
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

The rising popularity of disinfectants and antiseptics for both hospital and residential use is driving growth in the chlorhexidine gluconate (CHG) wipes market. The general availability of these products has majorly propelled sales in this industry. According to 2022 OEC data, the global trade of packaged disinfectants in retail sales reached USD 3.4 billion, with top exporters being China, Germany, the U.S., the UK, and Belgium. Particularly, the increased awareness about maintaining hygiene after the pandemic strike has significantly increased purchases in this field.

As per a study conducted by NLM, in December 2020, household disinfectant wipes usage per week was noticed to increase by 138% during the COVID-19 pandemic. Infection prevention practices are further stimulated by accelerated regulatory approvals and recommendations. This is attracting more pharmaceutical manufacturers to introduce new product pipelines, diversifying the chlorhexidine gluconate wipes market. Many are also unveiling extended applications of these disinfectants in veterinary care, expanding the market reach.

Key Chlorhexidine Gluconate (CHG) Wipes Market Insights Summary:

  • Regional Highlights:

    • North America CHG wipes market will secure around 35.60% share by 2035, driven by strong healthcare infrastructure and increased healthcare expenditure.
    • Asia Pacific market will achieve the fastest growth during the forecast timeline, driven by combined efforts from private and government institutions to promote disinfectant use.

  • Segment Insights:

    • The 5% concentration segment in the chlorhexidine gluconate wipes market market will secure a 69.9% share, driven by its efficacy in skin antisepsis and infection prevention, forecast year 2035.
    • The chg bath wipes segment is projected to hold a significant share by 2035, attributed to the increasing demand for critical patient care, particularly among the aging global population.

  • Key Growth Trends:

    • Growing incidences of healthcare-related infection
    • Rising demand for surgical disinfection

  • Major Challenges:

    • Arising questions about health impact
    • High production cost and pricing

  • Key Players: Becton, 3M, Stryker, Ecolab, PDI Limited, Nice-Pak, Carenow Medical Pvt. Ltd., Dickinson and Company, Cardinal Health, GAMA Healthcare Ltd., Lernapharm Inc., Pal International.

Global Chlorhexidine Gluconate (CHG) Wipes Market Forecast and Regional Outlook:

  • Market Size & Growth Projections:

    • 2025 Market Size: USD 214.09 million
    • 2026 Market Size: USD 225.27 million
    • Projected Market Size: USD 376.23 million by 2035
    • Growth Forecasts: 5.8% CAGR (2026-2035)

  • Key Regional Dynamics:

    • Largest Region: North America (35.6% Share by 2035)
    • Fastest Growing Region: Asia Pacific
    • Dominating Countries: United States, Germany, United Kingdom, Japan, China
    • Emerging Countries: China, India, Brazil, Mexico, South Korea

    • Last updated on : 8 September, 2025

Growth Drivers

  • Growing incidences of healthcare-related infection: Risk of infection during hospital stays or surgical interventions drives demand in the chlorhexidine gluconate wipes market. The rate of prevalence of these cases is concerning the authorities of such healthcare institutions such as hospitals and clinics as they increase medical expenditures. According to the National Healthcare Safety Network report, published in January 2024, the surgical site infection (SSI) standardized infection ratio (SIR) increased by 4% in the U.S. in 2022. The report further stated that SSI causes 20% of HAIs, increasing the annual hospitalization cost and reaching USD 3.3 billion. This is further pushing them to invest more in such disinfectant products.
  • Rising demand for surgical disinfection: The growing need for surgical sterilization and disinfection in the healthcare setting is remarkably contributing to the chlorhexidine gluconate (CHG) wipes market enlargement. Diversified usage of these wipes for patient skin, surgical instruments, and OT beds is creating varied channels of application for this sector. This inspires manufacturers to bring innovation to their production and accessibility to their distribution. The use of these products can significantly reduce the prolonged treatments, caused by SSIs benefiting both patients and healthcare institutions. This sector is further influenced by improving and strengthening global surgery outcomes, ensuring equitable and sustainable surgical care.

Challenges

  • Arising questions about health impact: Recently registered cases of skin irritation and allergic reaction due to using CHG-based products can limit the widespread of the chlorhexidine gluconate wipes market. The adverse effects may further impact consumer trust on the product’s effectiveness, hindering optimum and future adoption. This also creates an uncertainty of being replaced by new safer alternatives introduced in the healthcare industry. In addition, strict regulatory frameworks may restrict the usage of the wipes in several sectors, restricting market reach.  
  • High production cost and pricing: The required initial cost of production in the chlorhexidine gluconate wipes market may become expensive for many manufacturers. This restricts maximum participation from companies with limited budgets. Additionally, the affordability issues among low-income and non-hospital healthcare settings can refrain from adopting these products. This makes it difficult for suppliers and manufacturers to gain profitable revenue from the market, diluting their interest in future investments and participation.

Chlorhexidine Gluconate Wipes Market Size and Forecast:

Report Attribute Details

Base Year

2025

Forecast Period

2026-2035

CAGR

5.8%

Base Year Market Size (2025)

USD 214.09 million

Forecast Year Market Size (2035)

USD 376.23 million

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Chlorhexidine Gluconate Wipes Market Segmentation:

Concentration Segment Analysis

In terms of concentration, the 5% segment is projected to dominate chlorhexidine gluconate wipes market share of over 69.9% by 2035. The varied applications in the healthcare industry have made this segment one of the most preferable cleaning products. Their efficacy in skin antisepsis, infection prevention, and hygiene control is increasing the popularity of this concentration. It helps to kill a broad range of bacteria, viruses, and fungi, which attracts surgical centers to implement 5% CHG wipes in their medical procedures. Considering its efficiency and pivotal role in clinical and surgical disinfection, WHO placed the chlorhexidine digluconate 5% solution in its 2023 list of essential medicines.

Product Type Segment Analysis

Based on product type, the CHG bath wipes are estimated to captivate a significant share of the chlorhexidine gluconate wipes market by the end of 2035. The growth in this segment is majorly driven by the increasing demand for critical patient care. Specifically, the aging global population is creating a demanding consumer base for these personnel hygiene products. In 2020, NLM released an estimation of the total number of elderly in different health states in Thailand. The study projected the country to contain 153,640 bedridden patients by 2030. Similar countries such as Japan, China, and the U.S. have some of the oldest populations, making the CHG bath cleansers essential to maintain their health.

Our in-depth analysis of the global market includes the following segments:

Concentration
  • 2%
  • 5%

Product Type
  • CHG Bath Wipes
  • CHG/Alcohol-Based Wipes

Application
  • Surgical Site Infection
  • Central Line-Associated Bloodstream Infection
  • Catheter-Associated Urinary Tract Infections
  • Lens Cleaners

Distribution Channel
  • Hospital & Retail Pharmacies
  • Online Platforms
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Chlorhexidine Gluconate Wipes Market Regional Analysis:

North America Market Insights

North America chlorhexidine gluconate wipes market is predicted to capture revenue share of over 35.6% by 2035. The region is well-equipped with a strong healthcare infrastructure, which helps in sufficient medical product distribution, creating a profitable environment for this sector. In addition, the economic growth of this region has remarkably contributed to the increased healthcare expenditure, profiting this sector. According to the National Health Expenditure Account (NHEA), U.S. healthcare expenses increased by 7.5% in 2023, holding a value of USD 4.9 trillion, capturing 17.6% of the nation’s GDP.

Considering the rising incidences of healthcare-associated infection (HAI), the U.S. chlorhexidine gluconate (CHG) wipes market is growing notably. The country is garnering in-house forces to cope with the rising demand for such effective disinfectants to control the outrage. On that note, in May 2021, Mediline announced its acquisition of 40% domestic market share through the success of its ReadyPrep CHG cloths, launched in 2019. The pre-op skin antiseptic solution rolled out across the country, which inspired the company to invest USD 10 million to boost the manufacturing capacity, R&D, and clinical trials.

Canada is proactively empowering the regional chlorhexidine gluconate wipes market by investing heavily to prevent HAI spread in its healthcare settings. The country’s efforts are directly contributing to the development of this sector, as the financial support enhances new product discoveries and optimum adoption. For instance, in August 2021, Infection Prevention and Control Canada released a federal budget, highlighting the funding of USD 3 billion over five years to accommodate adequate healthcare settings. The investment directly targeted the development of long-term patient facilities to fight against infectious outbreaks.

APAC Market Insights

The Asia Pacific chlorhexidine gluconate wipes market is projected to witness the fastest growth during the forecast period. The combined efforts from both private and government institutions to promote the use of disinfectants have increased the popularity of CHG-based wipes in this region. Manufacturing powerhouses such as China and India are deliberately forcing healthcare facilities to adopt such effective cleaning and sterilizing products by securing a sufficient domestic supply.

India is strengthening the production and distribution channels of its domestic market by empowering local participants. With a strong emphasis on the pharma industry, the country is cultivating promising CHG solutions for healthcare disinfection. India is promoting the use of disinfectants. According to an NLM report, published in May 2022, the Infection Prevention and Control (IPC) program in India trained 2552 HCPs and 548 medical students to penetrate cleaning practices in healthcare. The program showcased a 30% increment in surface disinfection and cleaning through repeated training.

China is utilizing its manufacturing strength to make progress in the chlorhexidine gluconate wipes market. It is creating a well-established marketplace for both domestic and international leaders by using increased demand and enhanced production across the country. According to the 2022 OEC data, China secured its position among the top exporters of packaged disinfectants. It achieved USD 510 million export value of such products for retail sale to emerging landscapes such as the U.S., Germany, France, and Canada.

Chlorhexidine Gluconate (CHG) Wipes Market Share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Chlorhexidine Gluconate Wipes Market Players:

    The market is experiencing steady growth due to the active participation of the key players. They are introducing more effective CHG-based products to suit healthcare disinfection needs. Many are now putting efforts into accelerated approvals from regulatory frameworks such as the FDA to streamline and expand their product line. For instance, in 2020, Stryker launched Sage 2% chlorhexidine gluconate cloths with a 40% additional concentrated dose to prevent SSIs effectively. The FDA-approved CHG wipes are clinically validated to deliver excellence in disinfection. Such key players include:

    • Becton
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Dickinson and Company
    • 3M
    • Stryker
    • Cardinal Health
    • GAMA Healthcare Ltd
    • Carenow Medical Pvt. Ltd.
    • PDI Limited
    • Lernapharm Inc.
    • Pal International
    • Nice-Pak
    • Ecolab

Recent Developments

  • In July 2024, Ecolab launched a readily degradable wipe, Disinfectant 1 Wipe for hospital disinfection. The EPA-registered product is 100% plastic-free and is well-efficient to clean and disinfect hospitals and healthcare facilities with only 1 single wipe, offering less environmental impact.
  • In March 2020, 3M launched CHG antiseptic wipes, SOLUPREP for preparation of the patient’s skin before an invasive procedure. These wipes contain 2% chlorhexidine gluconate, making them capable of saving dry skin from bacterial skin infection.
  • Report ID: 1468
  • Published Date: Sep 08, 2025
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

customer-service Inquiry Before Buying

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of chlorhexidine gluconate wipes is assessed at USD 225.27 million.

The global chlorhexidine gluconate wipes market size surpassed USD 214.09 million in 2025 and is projected to witness a CAGR of over 5.8%, crossing USD 376.23 million revenue by 2035.

North America CHG wipes market will secure around 35.60% share by 2035, driven by strong healthcare infrastructure and increased healthcare expenditure.

Key players in the market include Becton, 3M, Stryker, Ecolab, PDI Limited, Nice-Pak, Carenow Medical Pvt. Ltd., Dickinson and Company, Cardinal Health, GAMA Healthcare Ltd., Lernapharm Inc., Pal International.

Chlorhexidine Gluconate (CHG) Wipes Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos